Sort
30,917 grants matching “tumor microenvironment”
Bifunctional Immunostimulatory Antibodies for Treatment of Breast Cancer
$336,150Atul Bedi · Johns Hopkins University · R01 · FY2015 · CA
Ovarian cancer gene therapy using HPV pseudovirion
$336,150T.-C. Wu · Johns Hopkins University · R01 · FY2016 · CA
A novel NKG2D-specific BiTE cancer immunotherapy
$336,150Charles L Sentman · Dartmouth College · R01 · FY2017 · CA
Ovarian cancer gene therapy using HPV pseudovirion
$336,150T.-C. Wu · Johns Hopkins University · R01 · FY2017 · CA
Ovarian cancer gene therapy using HPV pseudovirion
$336,150T.-C. Wu · Johns Hopkins University · R01 · FY2015 · CA
Bifunctional Immunostimulatory Antibodies for Treatment of Breast Cancer
$336,150Atul Bedi · Johns Hopkins University · R01 · FY2016 · CA
Annexin A2 as a mediator of pancreatic cancer metastases
$336,150Lei Zheng · Johns Hopkins University · R01 · FY2016 · CA
Cyclic Dinucleotides in Combinatorial Immunotherapy for Cancer
$336,150Young J. Kim · Johns Hopkins University · R01 · FY2013 · CA
Role of Tc17 cells in tumor immunotherapy
$336,150Drew M. Pardoll · Johns Hopkins University · R01 · FY2016 · CA
A novel NKG2D-specific BiTE cancer immunotherapy
$336,150Charles L Sentman · Dartmouth College · R01 · FY2016 · CA
Annexin A2 as a mediator of pancreatic cancer metastases
$336,150Lei Zheng · Johns Hopkins University · R01 · FY2013 · CA
Bifunctional Immunostimulatory Antibodies for Treatment of Breast Cancer
$336,150Atul Bedi · Johns Hopkins University · R01 · FY2017 · CA
Microenvironment mediated drug resistance in melanoma.
$336,129Keiran Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2014 · CA
PI3K-mediated metabolic alterations in the pre-neoplastic thyroid
$336,129Antonio Di Cristofano · Albert Einstein College Of Medicine · R01 · FY2014 · CA
Project 2 - Fatty Liver Predisposes to Metastasis: Role of Hepatic Stellate Cells
$336,117Ekihiro Seki · Cedars-Sinai Medical Center · P01 · FY2021 · CA
Micro-capsules for versatile multiplexed cytometry
$336,075Allon Moshe Klein · Harvard Medical School · R33 · FY2024 · CA
Project 3: Developing CAR T Cell Therapies to Target Tumor Heterogeneity in Advanced Prostate Cancer
$336,009Owen N Witte · University Of California Los Angeles · P50 · FY2022 · CA
Oncogenic Met Signaling in Urologic Malignancies
$335,956Donald Bottaro · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Office of Translational Resources
$335,912Thomas A Misteli · Division Of Basic Sciences - Nci · ZIC · FY2020 · CA
Imaging Core
$335,884Steven M Larson · Sloan-Kettering Inst Can Research · P01 · FY2010 · CA
Examining the role of the miR-181a:Wnt/B-catenin axis in ovarian cancer
$335,881Analisa Virginia Difeo · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Induction of Therapeutic Immunity in the Tumor Microenvironment
$335,873Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · CA
Mining B-catenin/BCL9 transcriptional complex for Multiple Myeloma therapeutics
$335,807Ruben D Carrasco · Dana-Farber Cancer Inst · R01 · FY2014 · CA
Cellular Mechanisms of Bone Quality in Metastatic Breast Cancer
$335,794Gregory R Mundy · Vanderbilt University · P50 · FY2012 · CA
Understanding How Breast Cancers Activate and Respond to the Systemic Environment
$335,768Sandra S McAllister · Brigham And Women'S Hospital · R01 · FY2014 · CA